PS2APP小鼠早期及纵向小胶质细胞激活而非淀粉样蛋白沉积预测认知结局
研究在PS2APP阿尔茨海默病转基因小鼠8至13月龄期间,连续进行TSPO与淀粉样蛋白PET成像,终点行水迷宫认知评估及免疫组化分析。结果显示8月龄时较高的TSPO表达预测更好的认知结局和更高的突触密度,TSPO激活进展至13月龄与认知保留呈中度关联,而淀粉样蛋白沉积与认知结局无关。首次在AD小鼠模型中联合纵向TSPO与淀粉样蛋白PET及终点认知测试,提示持续的小胶质细胞反应似乎赋予认知表现保留。
要点
- 8月龄时较高的TSPO表达预测PS2APP小鼠更好的认知结局和更高的突触密度。
- TSPO激活进展至13月龄与认知保留呈中度关联。
- 淀粉样蛋白沉积与认知结局无关,无论时间点。
核心结论
- 首次在AD小鼠模型中联合纵向TSPO与淀粉样蛋白PET及终点认知测试,表明持续的小胶质细胞反应似乎赋予认知表现保留。
研究设计与样本
- 在AD转基因小鼠模型(PS2APP)8至13月龄期间,连续进行TSPO与淀粉样蛋白PET成像,终点行水迷宫认知评估,随后进行小胶质细胞、淀粉样蛋白和突触密度的免疫组化分析。
主要发现
- 8月龄时较高的TSPO表达预测PS2APP小鼠更好的认知结局和更高的突触密度。
- TSPO激活进展至13月龄与认知保留呈中度关联。
- 淀粉样蛋白沉积与认知结局无关,无论时间点。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neuroinflammation may have beneficial or detrimental net effects on the cognitive outcome of Alzheimer disease (AD) patients. PET imaging with 18-kDa translocator protein (TSPO) enables longitudinal monitoring of microglial activation in vivo. Methods: We compiled serial PET measures of TSPO and amyloid with terminal cognitive assessment (water maze) in an AD transgenic mouse model (PS2APP) from 8 to 13 mo of age, followed by immunohistochemical analyses of microglia, amyloid, and synaptic density. Results: Better cognitive outcome and higher synaptic density in PS2APP mice was predicted by higher TSPO expression at 8 mo. The progression of TSPO activation to 13 mo also showed a moderate association with spared cognition, but amyloidosis did not correlate with the cognitive outcome, regardless of the time point. Conclusion: This first PET investigation with longitudinal TSPO and amyloid PET together with terminal cognitive testing in an AD mouse model indicates that continuing microglial response seems to impart preserved cognitive performance.
引用
- Focke C, Blume T, Zott B, et al. Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice. J Nucl Med. 2018. PMID: 30262517. doi:10.2967/jnumed.118.217703
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。